← TrialMatch
HomeTrials

Poly-L-Lactic Acid in Atrophic Acne Scars

Background: Management of atrophic acne scars remains challenging due to their heterogeneous morphology and suboptimal response to conventional therapies. Poly-L-lactic acid (PLLA), a biostimulatory agent, promotes neocollagenesis and has emerged as a promising therapeutic option. However, comparative data on different

Condition(s)Atrophic Acne Scarring
StatusRecruiting
PhaseNA
Study typeInterventional
SummaryBackground: Management of atrophic acne scars remains challenging due to their heterogeneous morphology and suboptimal response to conventional therapies. Poly-L-lactic acid (PLLA), a biostimulatory agent, promotes neocollagenesis and has emerged as a promising therapeutic option. However, comparative data on different delivery modalities of PLLA and their effects on dermal remodeling and skin physiology remain limited. Objective: To compare two delivery modalities of PLLA (injectable versus mono-thread) and evaluate their effects on dermal remodeling, clinical outcomes, and safety in atrophic acne scars. Methods: This prospective split-face study included 24 patients with atrophic acne scars. The right facial side was treated with a single session of PLLA mono-threads, while the left side
Who can participateInclusion Criteria: * included adult patients (≥18 years) of both sexes presenting with clinically diagnosed atrophic acne scars (Grades 2-4 according to the Goodman and Baron classification) Exclusion Criteria: * active acne lesions, pregnancy or lactation, bleeding disorders, keloid tendency, systemic diseases affecting wound healing, recent acne scar treatment within the past six months, and known hypersensitivity to PLLA components.
Ages18 Years to 40 Years
SexAll
Accepts healthy volunteersYes
Lead sponsorZagazig University
LocationsZagazig, Sharqia Province, Egypt
Start date2024-03-15
NCT IDNCT07523217
Official listinghttps://clinicaltrials.gov/study/NCT07523217

🔍 Search all trials →